Mkts

Pyxis Oncology, Inc.

NASDAQ: PYXS
$1.44+0.00 (+0.00%)
As of Nov 18, 1:29 PM ET

Key statistics

Day range
1.381.48
52-week range
1.035.55
Today
Open1.44
Previous close1.44
Volume—
Valuation
Market cap172.24M
P/E ratio—
EPS (TTM)-1.29
Income & risk
Dividend / yield—
Beta1.52
Avg volume1.13M
Discussion

PYXS News

Stories mentioning PYXS from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue2,820
Cost of Goods Sold
Gross Profit0.000.000.000.000.000.00
Operating Expenses
Research & Development19,98321,71117,80817,13317,04414,02417,74113,953
Sales General & Admin
Total Operating Expenses24,36022,914
Operating Income (Loss)(24,360)(18,295)(23,461)(19,750)(22,914)(40,069)(23,754)(20,032)
Interest Income218.00225.00242.0099.0084.0087.00194.00387.00
Interest Expense
Other Expense
Pretax Income(22,003)(18,071)(21,203)(17,301)
Tax Provision283.00
Net Income (Loss)(23,272)(18,106)(22,003)(18,354)(21,158)(35,571)(21,203)(17,301)
Earnings Per Share (Basic)(0.37)(0.29)(0.35)(0.30)(0.35)(0.61)(0.35)(0.29)
Earnings Per Share (Diluted)(0.37)(0.29)(0.35)(0.30)(0.35)(0.61)(0.35)(0.29)
Weighted Average Shares Outstanding (Basic)63,47062,14362,55761,91961,04958,44660,71560,496
Weighted Average Shares Outstanding (Diluted)63,47062,14362,55761,91961,04958,44660,71560,496

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About PYXS

Pyxis Oncology, Inc. (NASDAQ: PYXS) is a stock listed on the Nasdaq Stock Market under the ticker symbol PYXS. It last traded at $1.44 (Nov 18, 2026, 1:29 PM ET), unchanged on the day. That gives Pyxis Oncology a market capitalisation of $172.2M.

Over the past 52 weeks PYXS has traded between $1.03 and $5.55.

For the quarter ended Mar 31, 2026 it reported a net loss of $23.3M.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026—-$23.3M—
Dec 31, 2025—-$18.1M—
Sep 30, 2025—-$22.0M—
Jun 30, 2025$2.8M-$18.4M-650.9%

From Pyxis Oncology’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…